Industry
Third Wave Therapeutics
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
80.0%-7% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
Failure Rate
20.0%
1 terminated/withdrawn out of 5 trials
Success Rate
80.0%
-6.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
2 of 4 completed trials have results
Key Signals
2 with results
Enrollment Performance
Analytics
N/A
5(100.0%)
5Total
N/A(5)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (5)
Showing 5 of 5 trials
NCT06773013Not ApplicableCompleted
Safety and Effectiveness of Sonu for Pediatric Nasal Congestion
Role: lead
NCT06021795Not ApplicableCompleted
Sounds for Sleep Study in Patients Suffering From Moderate to Severe Insomnia
Role: lead
NCT06024564Not ApplicableTerminated
Sonu Real-World Use Clinical Study to Treat Moderate to Severe Nasal Congestion
Role: lead
NCT05821842Not ApplicableCompleted
Sonu Nasal Congestion Relief Study in Patients Suffering From Moderate to Severe Nasal Congestion
Role: lead
NCT04910139Not ApplicableCompleted
A User Study of the Soniflow System for Nasal Congestion Relief
Role: lead
All 5 trials loaded